Search PubMed⌕ Search

Biomedical subjects

S Hokari

Publications and source records attributed to S Hokari.

At least 55 records · Page 3Linked to original sources
PubMed1987

Deoxyuridine triphosphate nucleotidohydrolase activity and its correlation with multiplication of erythroid cells in rat spleen.

The administration of phenylhydrazine to rats brought about a marked increase in the dUTPase activity in the cytosol fractions of spleen and red blood cells; the activity began to increase with a two-day lag and reached the maximum at the 5th or 6th day of the phenylhydrazine treatment (13 and 5 times the control values in total activity in the spleen and red blood cells, respectively), and then the activity decreased. The activities of thymidine kinase and sigma-aminolevulinate synthase in the spleen and red blood cells also changed in parallel with that of dUTPase. The increases of these activities were suppressed completely by methotrexate, an inhibitor of DNA synthesis. The time courses of the enzyme activity changes in the red blood cells, however, were slightly behind those in the spleen. Thus, a close correlation was assumed between the dUTPase activity and the multiplication of erythroid cells in rat spleen.

Animals↗
PubMed1985

The effect of copper on intact cattle erythrocytes.

The effect of copper on intact cattle erythrocytes was investigated in vitro. When treated with copper, a decrease in the GSH content, accumulation of copper in the cell, loss of potassium and gain of sodium, cross-linking of membrane proteins, and echinocytic transformation were observed. All of these phenomena seem to be caused by a potent oxidant action of copper. These cytotoxic effects of copper were markedly inhibited by the addition of bovine serum albumin in the incubation medium. These results may help to understand the mechanism of hemolysis associated with copper poisoning in vivo.

Animals↗
PubMed1982

L-Phenylalanine inhibition of human alkaline phosphatases with p-nitrophenyl phosphate as substrate.

With p-nitrophenyl phosphate as the substrate, there reportedly is no organ-specific inhibition of alkaline phosphatase (EC 3.1.3.1) activity by L-phenylalanine. However, we found that at pH 10.0, with p-nitrophenyl phosphate as the substrate, L-phenylalanine obviously inhibits the alkaline phosphatase isoenzyme from human placenta, whereas there is little if any inhibition of the isoenzyme from human intestine. Because of the differing effects of substrates (p-nitrophenyl phosphate and phenyl phosphate) and their enzymic products (p-nitrophenol and phenol) for L-phenylalanine action on the placental alkaline phosphatase isoenzyme, we suggest that the isoenzyme--inhibitor--substrate complex and the effect of released phosphate on L-phenylalanine inhibition of the isoenzyme activity differ from each other.

Adult↗
PubMed1981

Inhibition of alkaline phosphatase by bismuth.

The interaction of alkaline phosphatase (EC 3.1.3.1) with bismuth was studied. Among the tested alkaline phosphatases, bismuth was found to be the most effective inhibitor of the placental enzyme. Partial denaturation of the placental enzyme by papain digestion had little effect, if any, on the inhibition. Bismuth inhibition of the placental enzyme activity was more progressive with mixed glycosidase treatment than with sialidase treatment. The pH activity profile of the mixed glycosidase-treated placental enzyme was clearly shifted in the presence of bismuth. The mixed glycosidase-treated placental enzyme/bismuth mixture was more heat labile than the non-treated placental enzyme. Based on the results of kinetic studies, the inhibition mechanism of the placental enzyme by bismuth was shown to be of the competitive type, and the Ki value and Hill coefficient of the mixed glycosidase-treated placental enzyme was found to be 92 mu mol/l and 2.25, respectively. L-Phenylalanine does not interfere with the inhibitory effect of bismuth on alkaline phosphatase. Inorganic phosphate, on the other hand, appears to disturb bismuth bindings.

Alkaline Phosphatase↗
PubMed1981

Lodish model and regulation of ribosomal protein synthesis by insulin-deficient chick embryo fibroblasts.

The production of ribosomal proteins in chick embryo fibroblasts that have been deprived of insulin is depressed in a much greater degree than that of most or all other cell proteins. Previous observations ruled out explanations for the preferential decrease in ribosomal protein formation that depend upon a selective destruction of ribosomal protein messages or a regulatory role for nascent ribosomal ribonucleic acid. The proposition has now been examined that ribosomal protein messenger ribonucleic acids (mRNAs) in the hormone-deficient chick embryo cells have a lower affinity for a limiting, early acting component of the initiating machinery than do most other cell messages and, in consequence, suffer from a translational disadvantage. The approach that was used depends upon the findings of Lodish and others that all mRNAs are not initiated with equal ease, that inhibitors of elongation favor the initiation of low-affinity mRNAs, and that agents that dampen an early step in initiation discriminate against the low-affinity messages. The idea was tested by comparing the effects of various inhibitors on the rates of synthesis of total cell protein and individual nonribosomal proteins, on the one hand, with those of individual ribosomal proteins, on the other. The results fit the Lodish model and are consistent with the conclusions that ribosomal protein mRNAs are more poorly initiated in the resulting fibroblasts than are most or all other cell messages and that this condition is largely or entirely responsible for the low rate of ribosomal protein formation.

Animals↗